Aster launches 20x perpetual contract tied to Oura’s upcoming IPO
AI Summary- Aster launched a synthetic perpetual contract tied to Oura Health’s planned IPO.
- Oura plans to offer 50 million shares at $40-$44 each, targeting roughly $2.2 billion.
- Oura filed its S-1 and began its Nasdaq IPO roadshow on September 21.